| Antiretroviral prophylaxis for HIV prevention in heterosexual men and women JM Baeten, D Donnell, P Ndase, NR Mugo, JD Campbell, J Wangisi, ... New England journal of medicine 367 (5), 399-410, 2012 | 3867 | 2012 |
| Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study R Heffron, D Donnell, H Rees, C Celum, N Mugo, E Were, G de Bruyn, ... The Lancet infectious diseases 12 (1), 19-26, 2012 | 550 | 2012 |
| Standards and operational guidance for ethics review of health-related research with human participants World Health Organization World Health Organization, 2011 | 293* | 2011 |
| Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners KA Thomson, J Hughes, JM Baeten, G John-Stewart, C Celum, CR Cohen, ... The Journal of infectious diseases 218 (1), 16-25, 2018 | 261* | 2018 |
| Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: a prospective implementation study in Kenya and Uganda JM Baeten, R Heffron, L Kidoguchi, NR Mugo, E Katabira, EA Bukusi, ... PLoS medicine 13 (8), e1002099, 2016 | 217 | 2016 |
| Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial JR Lingappa, B Lambdin, EA Bukusi, K Ngure, L Kavuma, M Inambao, ... PloS one 3 (1), e1411, 2008 | 216 | 2008 |
| Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial NR Mugo, T Hong, C Celum, D Donnell, EA Bukusi, G John-Stewart, ... Jama 312 (4), 362-371, 2014 | 166 | 2014 |
| Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis KK Mugwanya, D Donnell, C Celum, KK Thomas, P Ndase, N Mugo, ... The Lancet infectious diseases 13 (12), 1021-1028, 2013 | 147 | 2013 |
| Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa R Heffron, K Ngure, J Odoyo, N Bulya, E Tindimwebwa, T Hong, ... Gates open research 1, 2017 | 106 | 2017 |
| Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption KK Mugwanya, CW Hendrix, NR Mugo, M Marzinke, ET Katabira, K Ngure, ... PLoS medicine 13 (9), e1002132, 2016 | 103 | 2016 |
| Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95, 2021 | 92 | 2021 |
| Feasibility and acceptability of HIV self‐testing among pre‐exposure prophylaxis users in Kenya K Ngure, R Heffron, N Mugo, KA Thomson, E Irungu, N Njuguna, ... Journal of the International AIDS Society 20 (1), 21234, 2017 | 91 | 2017 |
| A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya K Ngure, N Mugo, C Celum, JM Baeten, M Morris, O Olungah, J Olenja, ... AIDS care 24 (4), 509-516, 2012 | 88 | 2012 |
| Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies R Heffron, K Ngure, N Mugo, C Celum, A Kurth, K Curran, JM Baeten JAIDS Journal of Acquired Immune Deficiency Syndromes 61 (1), 116-119, 2012 | 79 | 2012 |
| ‘If I am given antiretrovirals I will think I am nearing the grave’: Kenyan HIV serodiscordant couples’ attitudes regarding early initiation of antiretroviral therapy K Curran, K Ngure, B Shell-Duncan, S Vusha, NR Mugo, R Heffron, ... Aids 28 (2), 227-233, 2014 | 78 | 2014 |
| My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya K Ngure, JM Baeten, N Mugo, K Curran, S Vusha, R Heffron, C Celum, ... AIDS care 26 (10), 1283-1287, 2014 | 76 | 2014 |
| The preexposure prophylaxis revolution; from clinical trials to programmatic implementation NR Mugo, K Ngure, M Kiragu, E Irungu, N Kilonzo Current Opinion in HIV and AIDS 11 (1), 80-86, 2016 | 70 | 2016 |
| Development and validation of an immunoassay for tenofovir in urine as a real-time metric of antiretroviral adherence M Gandhi, P Bacchetti, WC Rodrigues, M Spinelli, CA Koss, PK Drain, ... EClinicalMedicine 2, 22-28, 2018 | 65 | 2018 |
| I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation K Ngure, R Heffron, K Curran, S Vusha, M Ngutu, N Mugo, C Celum, ... AIDS patient care and STDs 30 (2), 78-83, 2016 | 62 | 2016 |
| Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings M Gandhi, G Wang, R King, WC Rodrigues, M Vincent, DV Glidden, ... Aids 34 (2), 255-260, 2020 | 61 | 2020 |
Edwin WereProfessor of Reproductive Health, Moi UniversityVerified email at mu.ac.ke